Logo image of ESON.LS

ESTORIL SOL SGPS SA-REG SHS (ESON.LS) Stock Fundamental Analysis

ELI:ESON - Euronext Lisbon - PTESO0AM0000 - Common Stock - Currency: EUR

4.8  0 (0%)

Fundamental Rating

2

ESON gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. ESON scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ESON is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

ESON had negative earnings in the past year.
ESON had a positive operating cash flow in the past year.
Of the past 5 years ESON 4 years were profitable.
Of the past 5 years ESON 4 years had a positive operating cash flow.
ESON.LS Yearly Net Income VS EBIT VS OCF VS FCFESON.LS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M

1.2 Ratios

The 3 year average ROIC (13.45%) for ESON is well above the current ROIC(3.34%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -2.48%
ROE -6.68%
ROIC 3.34%
ROA(3y)9.62%
ROA(5y)3.75%
ROE(3y)14.71%
ROE(5y)5.57%
ROIC(3y)13.45%
ROIC(5y)N/A
ESON.LS Yearly ROA, ROE, ROICESON.LS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20 -20

1.3 Margins

ESON's Profit Margin has declined in the last couple of years.
ESON's Operating Margin has improved in the last couple of years.
ESON's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 10.01%
PM (TTM) N/A
GM 98.16%
OM growth 3YN/A
OM growth 5Y1.99%
PM growth 3YN/A
PM growth 5Y-18.34%
GM growth 3Y-0.1%
GM growth 5Y0.24%
ESON.LS Yearly Profit, Operating, Gross MarginsESON.LS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 60 80

More info and screens

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ESON is still creating some value.
Compared to 1 year ago, ESON has about the same amount of shares outstanding.
Compared to 5 years ago, ESON has about the same amount of shares outstanding.
The debt/assets ratio for ESON has been reduced compared to a year ago.
ESON.LS Yearly Shares OutstandingESON.LS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M
ESON.LS Yearly Total Debt VS Total AssetsESON.LS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

2.2 Solvency

ESON has an Altman-Z score of 1.02. This is a bad value and indicates that ESON is not financially healthy and even has some risk of bankruptcy.
ESON has a debt to FCF ratio of 0.29. This is a very positive value and a sign of high solvency as it would only need 0.29 years to pay back of all of its debts.
A Debt/Equity ratio of 0.00 indicates that ESON is not too dependend on debt financing.
Although ESON does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.29
Altman-Z 1.02
ROIC/WACC0.38
WACC8.71%
ESON.LS Yearly LT Debt VS Equity VS FCFESON.LS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M

2.3 Liquidity

A Current Ratio of 1.62 indicates that ESON should not have too much problems paying its short term obligations.
ESON has a Quick Ratio of 1.43. This is a normal value and indicates that ESON is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.62
Quick Ratio 1.43
ESON.LS Yearly Current Assets VS Current LiabilitesESON.LS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for ESON have decreased strongly by -135.34% in the last year.
Measured over the past years, ESON shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -16.29% on average per year.
The Revenue for ESON has decreased by -14.21% in the past year. This is quite bad
The Revenue has been growing slightly by 2.52% on average over the past years.
EPS 1Y (TTM)-135.34%
EPS 3YN/A
EPS 5Y-16.29%
EPS Q2Q%-194.48%
Revenue 1Y (TTM)-14.21%
Revenue growth 3Y17.83%
Revenue growth 5Y2.52%
Sales Q2Q%-12.18%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ESON.LS Yearly Revenue VS EstimatesESON.LS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
ESON.LS Yearly EPS VS EstimatesESON.LS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ESON reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ESON.LS Price Earnings VS Forward Price EarningsESON.LS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 32.61
EV/EBITDA N/A
ESON.LS Per share dataESON.LS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.49%, ESON has a reasonable but not impressive dividend return.
ESON's Dividend Yield is a higher than the S&P500 average which is at 2.33.
Industry RankSector Rank
Dividend Yield 3.49%

5.2 History

On average, the dividend of ESON grows each year by 18.43%, which is quite nice.
Dividend Growth(5Y)18.43%
Div Incr Years0
Div Non Decr Years0
ESON.LS Yearly Dividends per shareESON.LS Yearly Dividends per shareYearly Dividends per share 2019 2024 0.1 0.2 0.3 0.4

5.3 Sustainability

The earnings of ESON are negative and hence is the payout ratio. ESON will probably not be able to sustain this dividend level.
DP-145.2%
EPS Next 2YN/A
EPS Next 3YN/A
ESON.LS Yearly Income VS Free CF VS DividendESON.LS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M

More info and screens

ESTORIL SOL SGPS SA-REG SHS

ELI:ESON (3/5/2025, 7:00:00 PM)

4.8

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.13%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap57.55M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.49%
Yearly Dividend1.3
Dividend Growth(5Y)18.43%
DP-145.2%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.51
P/FCF 32.61
P/OCF 2.26
P/B 0.49
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.66
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.15
FCFY3.07%
OCF(TTM)2.13
OCFY44.31%
SpS9.49
BVpS9.88
TBVpS-5.36
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.48%
ROE -6.68%
ROCE 4.23%
ROIC 3.34%
ROICexc 4.49%
ROICexgc 50.66%
OM 10.01%
PM (TTM) N/A
GM 98.16%
FCFM 1.55%
ROA(3y)9.62%
ROA(5y)3.75%
ROE(3y)14.71%
ROE(5y)5.57%
ROIC(3y)13.45%
ROIC(5y)N/A
ROICexc(3y)48.44%
ROICexc(5y)N/A
ROICexgc(3y)112.04%
ROICexgc(5y)N/A
ROCE(3y)17.45%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y29.92%
ROICexc growth 3YN/A
ROICexc growth 5Y-19.41%
OM growth 3YN/A
OM growth 5Y1.99%
PM growth 3YN/A
PM growth 5Y-18.34%
GM growth 3Y-0.1%
GM growth 5Y0.24%
F-Score4
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.29
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 20.85%
Interest Coverage 250
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.62
Quick Ratio 1.43
Altman-Z 1.02
F-Score4
WACC8.71%
ROIC/WACC0.38
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)12.27%
Cap/Sales(5y)7.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-135.34%
EPS 3YN/A
EPS 5Y-16.29%
EPS Q2Q%-194.48%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-14.21%
Revenue growth 3Y17.83%
Revenue growth 5Y2.52%
Sales Q2Q%-12.18%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-64.59%
EBIT growth 3YN/A
EBIT growth 5Y4.56%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-95.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-39.71%
OCF growth 3YN/A
OCF growth 5Y-2.54%